Tutunculer Filiz, Saka Nurcin, Arkaya Selda Can, Abbasoglu Semra, Bas Firdevs
Department of Pediatrics, Faculty of Medicine, Trakya University, Edirne, Turkey.
Horm Res. 2009;72(6):331-6. doi: 10.1159/000249160. Epub 2009 Oct 21.
BACKGROUND/AIMS: Congenital adrenal hyperplasia (CAH) is characterized by adrenal insufficiency with or without salt wasting. It is also accompanied by adrenomedullary hypofunction. The aim of the present study was to investigate adrenomedullary function in patients with CAH due to 21-hydroxylase and 11beta-hydroxylase deficiencies and in age-matched normal subjects.
We measured plasma catecholamines (epinephrine and norepinephrine) and urine metanephrine in 44 patients with CAH, 32 due to 21-hydroxylase deficiency (17 patients with the salt-wasting form and 15 patients with the simple virilizing form), and 12 due to 11beta-hydroxylase deficiency, and in 25 healthy controls.
Plasma epinephrine and urine metanephrine levels were significantly higher in the controls than in patients with CAH (p = 0.02 and p < 0.001, respectively). Plasma norepinephrine levels were significantly lower in the controls than in patients with CAH (p < 0.001). Interestingly, patients with the salt-wasting form had lower norepinephrine levels in comparison to the other subgroups of CAH.
Despite the fact that CAH patients have insufficient epinephrine secretion, these patients have the ability to increase compensatory norepinephrine. However, this increase is much lower in patients with the salt-wasting form. These findings need to be confirmed by other studies.
背景/目的:先天性肾上腺皮质增生症(CAH)的特征是肾上腺功能不全,伴有或不伴有失盐。它还伴有肾上腺髓质功能减退。本研究的目的是调查21-羟化酶和11β-羟化酶缺乏所致CAH患者以及年龄匹配的正常受试者的肾上腺髓质功能。
我们测量了44例CAH患者的血浆儿茶酚胺(肾上腺素和去甲肾上腺素)和尿间甲肾上腺素,其中32例因21-羟化酶缺乏(17例为失盐型,15例为单纯男性化型),12例因11β-羟化酶缺乏,以及25名健康对照者的上述指标。
对照组的血浆肾上腺素和尿间甲肾上腺素水平显著高于CAH患者(分别为p = 0.02和p < 0.001)。对照组的血浆去甲肾上腺素水平显著低于CAH患者(p < 0.001)。有趣的是,与CAH的其他亚组相比,失盐型患者的去甲肾上腺素水平较低。
尽管CAH患者肾上腺素分泌不足,但这些患者有能力增加去甲肾上腺素的代偿性分泌。然而,失盐型患者的这种增加要低得多。这些发现需要其他研究予以证实。